Plains Venture PartnersPlains Venture PartnersPlains Venture PartnersPlains Venture Partners
  • About
  • Portfolio
  • Team
  • Investor Login

Sensulin wins science awards

    Home Entrepreneur Sensulin wins science awards
    NextPrevious

    Sensulin wins science awards

    By admin | Entrepreneur, News, Publish in TEN, SeedStep Angels | Comments are Closed | 5 March, 2013 | 0

    Copyright © 2013, The Oklahoma Publishing Company

    Oklahoma City-based Sensulin, LLC, a diabetes-focused biopharmaceutical company, received the 2013 Michael E. DeBakey Life Science Award at the recent second annual Texas Life Science Venture Forum in Houston.

    The DeBakey award is presented to the “undiscovered life science company with the highest potential to commercialize an important product.”

    Sensulin also received the Rice Alliance Most Promising Life Science Technology at the Houston event.

    Sensulin is developing a 24-hour glucose responsive insulin that would provide a patient’s entire daily need via a single dose. The technology could eliminate the need for separate basal and prandial insulin injections and profoundly improve the standard of care for type 1 and type 2 diabetes patients.

    “The goal of our technology is to give those with diabetes a chance at a normal life,” said Mike Moradi, Sensulin’s co-founder and CEO. “I have a vast family history of diabetes and this technology is particularly important to me.”

    Click here to read the article at newsok.com

     

    Mike Moradi, Sensulin, The Oklahoman

    NextPrevious
    • Disclaimer & Disclosure

    Oklahoma City Location

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305

    Click HERE for directions.

    Tulsa Location

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592

    Click HERE for directions.

    • Disclaimer & Disclosure
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • About
    • Portfolio
    • Team
    • Funds
    • Investor Login
    Plains Venture Partners